{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T20:50:25Z","timestamp":1781729425627,"version":"3.54.5"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.msard.2024.105632","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T15:54:45Z","timestamp":1713196485000},"page":"105632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Latent tuberculosis prevalence, diagnosis and treatment in Multiple Sclerosis as a strategy for reducing infection reactivation during immunosuppressant therapy"],"prefix":"10.1016","volume":"86","author":[{"given":"Gelvana Fl\u00e1vio Barreto","family":"Reis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea de Carvalho Anacleto Ferrari","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitan Naaman","family":"Berezin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2024.105632_bib0009","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7224\/1537-2073.2019-015","article-title":"Prevalence of latent tuberculosis in the multiple sclerosis clinic and effect of multiple sclerosis treatment on tuberculosis testing","volume":"23","author":"Bouley","year":"2021","journal-title":"Int. J. MS. Care"},{"key":"10.1016\/j.msard.2024.105632_bib0002","series-title":"Manual De Recomenda\u00e7\u00f5es Para o Controle Da Tuberculose no Brasil","article-title":"Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Vigil\u00e2ncia das Doen\u00e7as Transmiss\u00edveis","year":"2019"},{"key":"10.1016\/j.msard.2024.105632_bib0013","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Ci\u00eancia, Tecnologia, Inova\u00e7\u00e3o e Insumos Estrat\u00e9gicos em Sa\u00fade. Departamento de Gest\u00e3o e Incorpora\u00e7\u00e3o de Tecnologias e Inova\u00e7\u00e3o em Sa\u00fade. Coordena\u00e7\u00e3o-Geral de Gest\u00e3o de Tecnologias em Sa\u00fade. Coordena\u00e7\u00e3o de Monitoramento e Avalia\u00e7\u00e3o de Tecnologias em Sa\u00fade. Rifapentina + isoniazida para o tratamento da Infec\u00e7\u00e3o Latente pelo Mycobacterium Tuberculosis (ILTB): relat\u00f3rio de recomenda\u00e7\u00e3o n. 526. Bras\u00edlia: MS; 2020 https:\/\/www.gov.br\/conitec\/pt-br\/midias\/consultas\/relatorios\/2020\/relatorio_rifapentina-isoniazida_iltb_526_2020_final.pdf. (accessed 26 May 2023)."},{"key":"10.1016\/j.msard.2024.105632_bib0012","series-title":"Nota Informativa n\u00b0 5\/2021-CGDR\/DCCI\/SVS\/MS Disp\u00f5e sobre Recomenda\u00e7\u00f5es Infec\u00e7\u00e3o Latente atualiza\u00e7\u00e3o Do Tratamento das Da Pelo Mycobacterium tuberculosis Com a Disponibiliza\u00e7\u00e3o Da Rifapentina","year":"2021"},{"key":"10.1016\/j.msard.2024.105632_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103184","article-title":"Latent tuberculosis infection reactivation in patients with multiple sclerosis in use of disease-modifying therapies: a systematic review","volume":"55","author":"Dantas","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"8","key":"10.1016\/j.msard.2024.105632_bib0001","doi-asserted-by":"crossref","first-page":"ofy174","DOI":"10.1093\/ofid\/ofy174","article-title":"Infectious complications of multiple sclerosis therapies: implications for screening, prophylaxis, and management","volume":"5","author":"Epstein","year":"2018","journal-title":"Open. Forum. Infect. Dis."},{"issue":"11","key":"10.1016\/j.msard.2024.105632_bib0010","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1586\/14737175.2014.962517","article-title":"How do we manage and treat a patient with multiple sclerosis at risk of tuberculosis?","volume":"14","author":"Fragoso","year":"2014","journal-title":"Expert. Rev. NeurOther"},{"issue":"12","key":"10.1016\/j.msard.2024.105632_bib0017","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/acn3.491","article-title":"Infectious risk stratification in multiple sclerosis patients receiving immunotherapy","volume":"4","author":"Graf","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"8","key":"10.1016\/j.msard.2024.105632_bib0015","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and treatment of multiple sclerosis: a review","volume":"325","author":"McGinley","year":"2021","journal-title":"JAMa"},{"issue":"3","key":"10.1016\/j.msard.2024.105632_bib0008","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/1352458520952311","article-title":"The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: a Delphi consensus statement","volume":"27","author":"Moiola","year":"2021","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2024.105632_bib0007","article-title":"Diagnosis and treatment of latent tuberculosis in patients with multiple sclerosis, expert consensus. On behalf of the Colombian Association of Neurology, Committee of Multiple Sclerosis","volume":"4","author":"Navas","year":"2018","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2024.105632_bib0011","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMcp2108501","article-title":"Latent tuberculosis infection","volume":"385","author":"Shah","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2024.105632_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104840","article-title":"Latin American consensus recommendations on the risk of infections in people with multiple sclerosis treated with disease modifying drugs","volume":"77","author":"Silva","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2024.105632_bib0014","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2024.105632_bib0003","unstructured":"World Health Organization. Guidelines On the Management of Latent Tuberculosis Infection [Internet]. Geneva: WHO; 2015 [cited 2022 Aug 12]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK293818\/pdf\/Bookshelf_NBK293818.pdf."},{"key":"10.1016\/j.msard.2024.105632_bib0005","article-title":"WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment","year":"2020","journal-title":"Geneva: WHO"},{"key":"10.1016\/j.msard.2024.105632_bib0004","unstructured":"World Health Organization. Global Tuberculosis Report 2022. Geneva: WHO, 2022. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/363752\/9789240061729-eng.pdf?sequence=1. (accessed 10 Sep 2022)."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824002098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824002098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T23:21:51Z","timestamp":1715037711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824002098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":17,"alternative-id":["S2211034824002098"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.105632","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Latent tuberculosis prevalence, diagnosis and treatment in Multiple Sclerosis as a strategy for reducing infection reactivation during immunosuppressant therapy","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.105632","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105632"}}